ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 36 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $306,000 | -8.9% | 19,623 | -23.8% | 0.00% | – |
Q3 2016 | $336,000 | +189.7% | 25,739 | +52.5% | 0.00% | – |
Q2 2016 | $116,000 | -86.4% | 16,878 | -81.3% | 0.00% | – |
Q1 2016 | $851,000 | -11.3% | 90,105 | -5.4% | 0.00% | – |
Q4 2015 | $959,000 | -18.7% | 95,220 | +15.4% | 0.00% | – |
Q3 2015 | $1,180,000 | – | 82,478 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
Founders Capital Management | 3,000 | $9,000 | 0.01% |
King Wealth Management Group | 16,000 | $33,000 | 0.01% |
Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |